Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Gliosarcoma 8Glioblastoma 8Central Nervous System Neoplasms 8Sarcoma 7Brain Neoplasms 6Glioma 5Astrocytoma 4Osteosarcoma 3Oligodendroglioma 3Neuroectodermal Tumors, Primitive 2Neuroblastoma 2Medulloblastoma 2AIDS-related Kaposi sarcoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrent Uterine Corpus Sarcoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pancreatic Neoplasms 1

Interventions

Paclitaxel 7Specimen Handling 6Radiotherapy 4Magnetic Resonance Spectroscopy 4Biopsy 4pembrolizumab 3Taxes 3Nivolumab 3Carboplatin 3trastuzumab deruxtecan 2olaparib 2ceralasertib 2aflibercept 2X-Rays 2Psychiatric Rehabilitation 2Irinotecan 2Ipilimumab 2Immunoglobulin G 2Ifosfamide 2Gene Expression Profiling 2Fulvestrant 2Filgrastim 2Fentanyl 2Doxorubicin 2Bevacizumab 2trifluridine tipiracil drug combination 1toripalimab 1tinostamustine 1spartalizumab 1selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Thalidomide × Sarcoma × Clear all
NCT00006005 2013-06-21

Thalidomide in Treating Patients With Gynecologic Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Sarcoma, Endometrial Neoplasms, Sarcoma, Endometrial Stromal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡